NCT04242238: Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas |
|
|
| Active, not recruiting | 1 | 32 | US | DCC-3014, Avelumab | Memorial Sloan Kettering Cancer Center, ENABLE MEDICINE | Sarcoma, Advanced Sarcoma, High Grade Sarcoma, Leiomyosarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, Dedifferentiated Liposarcoma | 01/25 | 01/25 | | |
